Novartis Q4 2022 Results Investor Presentation

Novartis AG presented its Q4 2022 financial results and 2023 priorities to investors on February 1, 2023. The presentation outlines the company's strategic review of Sandoz, planned as a 100% spin-off to focus on innovative medicines. Key topics include financial performance, forward-looking guidance, and operational updates across the pharmaceutical business.